Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

FHS
June 26, 2024
5:14 am

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

Ford Motor Company F stock analysis & what to expect next with F stock

August 11, 2023

Updated: GSK unintimidated by RSV vaccine uptake challenges, Shingrix US sales drop

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 1, 2024

HF-158K1 by HighField Biopharmaceuticals for Gastric Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Gastric Cancer.

July 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.